Search Results - "Swierczynska, Monika"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Nasal provocation tests with lysine aspirin by Kupczyk, Maciej, Swierczynska-Kepa, Monika, Kuna, Piotr, Nizankowska-Mogilnicka, Ewa, Szczeklik, Andrzej

    Published in Postȩpy dermatologii i alergologii (01-05-2010)
    “…Provocation tests with aspirin reliably prove aspirin hypersensitivity in patients with a history of prior reaction to non-steroidal anti-inflammatory drugs…”
    Get full text
    Journal Article
  5. 5

    Nasal versus bronchial and nasal response to oral aspirin challenge: Clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis by Swierczynska, Monika, Nizankowska-Mogilnicka, Ewa, Zarychta, Jacek, Gielicz, Anna, Szczeklik, Andrzej

    Published in Journal of allergy and clinical immunology (01-11-2003)
    “…Aspirin-induced asthma/rhinitis (AIAR) is characterized by the altered metabolism of leukotrienes and proinflammatory prostaglandins. The basal and…”
    Get full text
    Journal Article
  6. 6

    Aspirin-induced rhinitis and asthma by Szczeklik, Andrew, Nizankowska, Ewa, Sanak, Marek, Swierczynska, Monika

    “…Interesting findings relating to aspirin-induced asthma recently emerged. In this distinct clinical syndrome, aspirin and most other nonsteroidal…”
    Get full text
    Journal Article
  7. 7

    Standards of nasal provocation tests by Samolinski, Boleslaw, Rapiejko, Piotr, Krzych-Falta, Edyta, Gotlib, Tomasz, Emeryk, Andrzej, Buczylko, Krzysztof, Chelminska, Marta, Chelminski, Konrad, Niedoszytko, Marek, Swierczynska-Kepa, Monika, Kupczyk, Maciej, Sybilsk, Adam, Mazurek, Henryk, Gawlik, Radoslaw

    Published in Postȩpy dermatologii i alergologii (01-05-2010)
    “…The nasal allergen provocation test (NAPT) plays an important role in diagnosis of allergy. It is based on the natural reaction of the nasal mucosa after…”
    Get full text
    Journal Article
  8. 8

    A case of emphysema suggesting cystic lung disease in computer tomography by Swierczyńska, Monika, Mastalerz, Lucyna, Papla, Bolesław, Sładek, Krzysztof, Nizankowska-Mogilnicka, Ewa

    Published in Przeglad lekarski (2005)
    “…Pulmonary emphysema is anatomically defined as abnormal persistent enlargement of the air spaces distal to the terminal bronchioles, accompanied by destruction…”
    Get more information
    Journal Article
  9. 9

    Functional assessment of posterior cordotomy in patients with bilateral vocal fold paralysis by Strek, Paweł, Zagólski, Olaf, Swierczyńska, Monika, Nizankowska, Ewa, Szałapata-Kraśniak, Marta

    Published in Otolaryngologia Polska (2004)
    “…Surgical treatment of bilateral vocal fold paralysis must be undertaken if such a condition lasts 6-12 months or longer and causes dyspnoea. The purpose of the…”
    Get more information
    Journal Article
  10. 10

    Sicca syndrome and pulmonary fibrosis in a woman with anti-RO and anti-Jo-1 antibodies by Bochenek, Grazyna, Swierczyńska, Monika, Wilańska, Joanna, Nizankowska-Mogilnicka, Ewa, Musiał, Jacek

    Published in Polskie archiwum medycyny wewne̦trznej (01-12-2003)
    “…We describe a case of a 52-year old woman with clinical and immunological features of sicca syndrome associated with pulmonary fibrosis, anti-Jo-1, and…”
    Get more information
    Journal Article
  11. 11

    Nonallergic rhinitis with eosinophilia syndrome: state of knowledge by Swierczyńska, Monika, Strek, Paweł, Składzień, Jacek, Nizankowska-Mogilnicka, Ewa, Szczeklik, Andrzej

    Published in Otolaryngologia Polska (2003)
    “…The aim of our article was to present the actual state of knowledge of the non-allergic rhinitis with eosinophilia syndrome (NARES). NARES is characterized by…”
    Get more information
    Journal Article
  12. 12

    Tolerability of Asacard--controlled-release aspirin and aspirin-induced asthma by Bochenek, Grazyna, Swierczyńska, Monika, Nizankowska-Mogilnicka, Ewa, Vivet, Phillippe, Gicquel, Michel, Szczeklik, Andrzej

    Published in Polskie archiwum medycyny wewne̦trznej (01-03-2002)
    “…Asacard is a microcapsulated, controlled-release form of acetylsalicylic acid, which delivers very low but constant amount of the drug directly into the…”
    Get more information
    Journal Article
  13. 13